Skip to main content
. 2017 Nov 3;7(11):e017387. doi: 10.1136/bmjopen-2017-017387

Figure 3.

Figure 3

Kaplan-Meier survival function of the patients treated with ddTMZ+mEHT (n=54) since diagnosis (A) and since first mEHT session (A1). C, censored; ddTMZ, dose-dense temozolomide; mEHT, modulated electrohyperthermia; S, survival function.